2021 Q4 Form 10-K Financial Statement

#000156459022011575 Filed on March 24, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $3.665M $12.29M $2.370M
YoY Change 54.64% 185.26%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.162M $14.70M $4.280M
YoY Change -26.12% 5.36% 21.25%
% of Gross Profit
Research & Development $4.543M $18.99M $4.910M
YoY Change -7.47% 6.4% 11.34%
% of Gross Profit
Depreciation & Amortization $260.0K $1.100M $350.0K
YoY Change -25.71% -21.76% -35.19%
% of Gross Profit
Operating Expenses $7.705M $33.69M $9.190M
YoY Change -16.16% 88.73% 15.74%
Operating Profit -$21.40M
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$2.557M -$8.008M -$350.0K
YoY Change 630.57% 502.11% -23.91%
Pretax Income -$6.597M -$29.41M -$7.170M
YoY Change -7.99% -4.9% -14.64%
Income Tax
% Of Pretax Income
Net Earnings -$6.272M -$28.46M -$7.050M
YoY Change -11.04% 60.32% -13.71%
Net Earnings / Revenue -171.13% -231.51% -297.47%
Basic Earnings Per Share -$6.07
Diluted Earnings Per Share -$1.280M -$6.070M -$1.826M
COMMON SHARES
Basic Shares Outstanding 4.688M
Diluted Shares Outstanding 4.688M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.04M $45.04M $40.00M
YoY Change 12.61% 12.61% 222.58%
Cash & Equivalents $45.04M $41.20M $39.98M
Short-Term Investments
Other Short-Term Assets $780.0K $3.862M $133.0K
YoY Change 486.47% -21.18% -16.88%
Inventory
Prepaid Expenses $1.823M $2.228M
Receivables $3.664M $3.664M $2.400M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $52.57M $52.57M $47.26M
YoY Change 11.23% 11.14% 57.57%
LONG-TERM ASSETS
Property, Plant & Equipment $2.379M $3.963M $2.815M
YoY Change -15.49% -27.95% -28.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $68.00K $68.00K $746.0K
YoY Change -90.88% -90.29% -1.45%
Total Long-Term Assets $4.031M $4.031M $6.283M
YoY Change -35.84% -34.98% -73.16%
TOTAL ASSETS
Total Short-Term Assets $52.57M $52.57M $47.26M
Total Long-Term Assets $4.031M $4.031M $6.283M
Total Assets $56.60M $56.60M $53.55M
YoY Change 5.7% 5.8% 0.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.462M $3.462M $5.600M
YoY Change -38.18% -38.18% -56.92%
Accrued Expenses $3.096M $3.096M $3.700M
YoY Change -16.32% -16.32% -17.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $11.67M $11.67M $5.000M
YoY Change 133.34% 133.34% -74.83%
Total Short-Term Liabilities $34.76M $34.76M $14.54M
YoY Change 139.06% 139.7% -61.98%
LONG-TERM LIABILITIES
Long-Term Debt $3.707M $3.707M $20.10M
YoY Change -81.56% -81.56%
Other Long-Term Liabilities $16.92M $16.92M $2.400M
YoY Change 605.04% 605.04% -27.27%
Total Long-Term Liabilities $20.63M $20.63M $22.50M
YoY Change -8.32% -8.32% 581.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $34.76M $34.76M $14.54M
Total Long-Term Liabilities $20.63M $20.63M $22.50M
Total Liabilities $55.39M $55.39M $36.95M
YoY Change 49.88% 49.69% -11.1%
SHAREHOLDERS EQUITY
Retained Earnings -$214.1M -$185.6M
YoY Change 15.33% 10.57%
Common Stock $215.3M $202.2M
YoY Change 6.47% 12.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.216M $1.216M $16.59M
YoY Change
Total Liabilities & Shareholders Equity $56.60M $56.60M $53.55M
YoY Change 5.7% 5.8% 0.26%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$6.272M -$28.46M -$7.050M
YoY Change -11.04% 60.32% -13.71%
Depreciation, Depletion And Amortization $260.0K $1.100M $350.0K
YoY Change -25.71% -21.76% -35.19%
Cash From Operating Activities -$3.880M -$21.68M -$6.120M
YoY Change -36.6% -26.06% 20.0%
INVESTING ACTIVITIES
Capital Expenditures -$118.0K -$713.0K -$90.00K
YoY Change 31.11% -910.23%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$118.0K -$713.0K -$90.00K
YoY Change 31.11% -102.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $10.23M
YoY Change
Debt Paid & Issued, Net $10.55M
YoY Change -52.27%
Cash From Financing Activities -3.076M 26.16M 21.24M
YoY Change -114.48% 9.58% -16438.46%
NET CHANGE
Cash From Operating Activities -3.880M -21.68M -6.120M
Cash From Investing Activities -118.0K -713.0K -90.00K
Cash From Financing Activities -3.076M 26.16M 21.24M
Net Change In Cash -7.074M 3.769M 15.03M
YoY Change -147.07% -83.31% -387.38%
FREE CASH FLOW
Cash From Operating Activities -$3.880M -$21.68M -$6.120M
Capital Expenditures -$118.0K -$713.0K -$90.00K
Free Cash Flow -$3.762M -$20.97M -$6.030M
YoY Change -37.61% -28.7% 18.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.071
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.071
CY2019Q1 apvo Pre Funded Warrants And Rights Outstanding Term
PreFundedWarrantsAndRightsOutstandingTerm
P10Y
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#RoyaltyMember
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Auditor Name
AuditorName
Moss Adams LLP
CY2021 dei Auditor Location
AuditorLocation
Seattle, WA
CY2021 dei Auditor Firm
AuditorFirmId
659
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45044000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39979000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
1259000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
2555000
CY2021Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
3664000
CY2020Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
2369000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1823000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2228000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
780000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
133000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
52570000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
47264000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2815000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1584000
CY2021Q4 apvo Liabilities Held For Sale Current
LiabilitiesHeldForSaleCurrent
15465000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11667000
CY2021Q4 apvo Liabilities Held For Sale Non Current
LiabilitiesHeldForSaleNonCurrent
15580000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
3707000
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
20054000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1341000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2360000
CY2021Q4 us-gaap Liabilities
Liabilities
55385000
CY2020Q4 us-gaap Liabilities
Liabilities
36953000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4898143
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4898143
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4410909
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4410909
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
47000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
46000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
215232000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
202154000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-214063000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-185606000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1216000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
16594000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56601000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53547000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12292000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4309000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2104000
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-29408000
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4000
CY2020 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
14338000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2104000
CY2021 apvo Increase Decrease In Royalties Receivable
IncreaseDecreaseInRoyaltiesReceivable
1295000
CY2020 apvo Increase Decrease In Royalties Receivable
IncreaseDecreaseInRoyaltiesReceivable
2369000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-436000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1112000
CY2021 apvo Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
1138000
CY2020 apvo Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
1025000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1915000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-702000
CY2021 apvo Increase Decrease In Long Term Operating Lease Liability
IncreaseDecreaseInLongTermOperatingLeaseLiability
1019000
CY2020 apvo Increase Decrease In Long Term Operating Lease Liability
IncreaseDecreaseInLongTermOperatingLeaseLiability
967000
CY2020 apvo Increase Decrease In Assets And Liabilities Held For Sale
IncreaseDecreaseInAssetsAndLiabilitiesHeldForSale
-1719000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29318000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-11000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11842000
CY2020 apvo Proceeds From Exercise Of Stock Options Value
ProceedsFromExerciseOfStockOptionsValue
-23000
CY2020 apvo Proceeds From Exercise Of Warrants Value
ProceedsFromExerciseOfWarrantsValue
-21235000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
22104000
CY2021 apvo Repayments Under Liability Related To Sale Of Future Royalties
RepaymentsUnderLiabilityRelatedToSaleOfFutureRoyalties
8627000
CY2021 apvo Proceeds From Sale Of Future Royalties
ProceedsFromSaleOfFutureRoyalties
35000000
CY2021 apvo Transaction Costs From Sale Of Future Royalties
TransactionCostsFromSaleOfFutureRoyalties
1100000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
220000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23000
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
985000
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
21235000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10233000
CY2020 apvo Payment Of Tax Liability For Vested Equity Awards
PaymentOfTaxLiabilityForVestedEquityAwards
11000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23874000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22588000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46303000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
42534000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1255000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-17750000
CY2021 apvo Proceeds From Exercise Of Stock Options Value
ProceedsFromExerciseOfStockOptionsValue
-218000
CY2021 apvo Proceeds From Exercise Of Warrants Value
ProceedsFromExerciseOfWarrantsValue
-984000
CY2021Q4 apvo Number Of Technology Platforms
NumberOfTechnologyPlatforms
2
CY2020Q1 apvo Fractional Shares Reverse Stock Split
FractionalSharesReverseStockSplit
0
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent liabilities in the consolidated financial statements and accompanying notes. Estimates are used for, but not limited to, forecasted royalties, effective interest rates, clinical accruals, useful lives of equipment, commitments and contingencies, and stock-based compensation. Given the global economic climate and additional or unforeseen effects from the ongoing COVID-19 pandemic, these estimates are becoming more challenging, and actual results could differ materially from those estimates.</p>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject Aptevo to concentrations of credit risk consist primarily of cash and cash equivalents, certain investments and royalties receivable. Aptevo places its cash and cash equivalents with high quality financial institutions and may maintain cash balances in excess of insured limits. Management believes that the financial risks associated with its cash and cash equivalents are minimal.</p>
CY2021Q1 apvo Proceeds From Sale Of Investments
ProceedsFromSaleOfInvestments
35000000
CY2021Q1 apvo Payment Of Royalty Purchase Agreement Percentage
PaymentOfRoyaltyPurchaseAgreementPercentage
1.90
CY2021Q1 apvo Payment Of Royalty Interest Percentage
PaymentOfRoyaltyInterestPercentage
0.50
CY2021Q1 apvo Milestone Payment
MilestonePayment
10000000
CY2021Q1 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
500000
CY2020 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
14300000
CY2020Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
14300000
CY2020 apvo Cash Payment Received
CashPaymentReceived
29250000
CY2020Q4 us-gaap Escrow Deposit
EscrowDeposit
750000
CY2020 apvo Proceeds From Divestiture Of Businesses Consideration Gross
ProceedsFromDivestitureOfBusinessesConsiderationGross
30000000
CY2020 apvo Net Carrying Value Of Assets Transferred
NetCarryingValueOfAssetsTransferred
13376000
CY2020 apvo Transaction Cost
TransactionCost
1880000
CY2020Q4 apvo Minimum Transition Services Agreement Tsa Fund
MinimumTransitionServicesAgreementTSAFund
406000
CY2020 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
14338000
CY2020 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
-1582000
CY2020 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
14338000
CY2021 apvo Discontinued Operating Gain On Contingent Consideration
DiscontinuedOperatingGainOnContingentConsideration
460000
CY2021 apvo Disposal Group Including Discontinued Operations Deferred Revenue
DisposalGroupIncludingDiscontinuedOperationsDeferredRevenue
491000
CY2020 apvo Disposal Group Including Discontinued Operations Deferred Revenue
DisposalGroupIncludingDiscontinuedOperationsDeferredRevenue
417000
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
951000
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
13173000
CY2021Q1 apvo Disposal Group Including Discontinued Operations Deferred Revenue
DisposalGroupIncludingDiscontinuedOperationsDeferredRevenue
500000
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
0
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
100000
CY2020 apvo Investing Non Cash Items
InvestingNonCashItems
0
CY2021 apvo Cash Equivalents Maturity Period
CashEquivalentsMaturityPeriod
P90D
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1259000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2555000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42534000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14658000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13958000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12279000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11143000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2379000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2815000
CY2021 us-gaap Depreciation
Depreciation
1100000
CY2020 us-gaap Depreciation
Depreciation
1200000
CY2020Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
25000.0
CY2021Q1 apvo Payment Of Amount Outstanding
PaymentOfAmountOutstanding
10000000.0
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5000000.0
CY2021Q1 apvo Amendment Fees
AmendmentFees
600000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
12333000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
2252000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
1435000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
16020000
CY2021Q1 apvo Proceeds From Sale Of Investments
ProceedsFromSaleOfInvestments
35000000.0
CY2021Q1 apvo Payment Of Royalty Purchase Agreement Percentage
PaymentOfRoyaltyPurchaseAgreementPercentage
1.90
CY2021Q1 apvo Payment Of Royalty Interest Percentage
PaymentOfRoyaltyInterestPercentage
0.50
CY2021 us-gaap Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
35000000
CY2021 apvo Non Cash Interest Expense
NonCashInterestExpense
5772000
CY2021 us-gaap Payments For Royalties
PaymentsForRoyalties
8627000
CY2021Q4 apvo Liability Related To Sale Of Future Royalties
LiabilityRelatedToSaleOfFutureRoyalties
31045000
CY2021 apvo Liability Related To Sale Of Future Royalties Current
LiabilityRelatedToSaleOfFutureRoyaltiesCurrent
-15465000
CY2021Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1100000
CY2021 apvo Liability Related To Sale Of Future Royalties Non Current
LiabilityRelatedToSaleOfFutureRoyaltiesNonCurrent
15580000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
6000
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2021 us-gaap Lease Cost
LeaseCost
1562000
CY2020 us-gaap Lease Cost
LeaseCost
1587000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1584000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2722000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1387000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
1480000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1294000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1399000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2693000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
333000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2360000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
81146
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
325904
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
400000
CY2021 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
951000
CY2020 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
13173000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-28457000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-17750000
CY2021 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-6.27
CY2020 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-9.12
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.20
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
3.88
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.07
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.23
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4687952
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3390919
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
18.20
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
18.20
CY2021 apvo Number Of Common Stock Shares To Be Issued Upon Exercise Of Warrants
NumberOfCommonStockSharesToBeIssuedUponExerciseOfWarrants
54105
CY2020 apvo Number Of Common Stock Shares To Be Issued Upon Exercise Of Warrants
NumberOfCommonStockSharesToBeIssuedUponExerciseOfWarrants
1166735
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1000000.0
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
21200000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1643000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1255000
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
100000
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1000000.0
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
21200000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1600000
CY2021 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2021 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
200000
CY2020 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
300000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
900000
CY2019Q1 apvo Prefunded Warrant Expiration Date
PrefundedWarrantExpirationDate
2029-03-11
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
18.20
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
18.20
CY2021 apvo Number Of Common Stock Shares To Be Issued Upon Exercise Of Warrants
NumberOfCommonStockSharesToBeIssuedUponExerciseOfWarrants
54105
CY2020 apvo Number Of Common Stock Shares To Be Issued Upon Exercise Of Warrants
NumberOfCommonStockSharesToBeIssuedUponExerciseOfWarrants
1166735
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-29408000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-30923000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29408000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
33520000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
34118000
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
235000
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
306000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
986000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1042000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
3743000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
3626000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2023000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2345000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
3253000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
2241000
CY2021Q4 apvo Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
496000
CY2020Q4 apvo Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
772000
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
456000
CY2021Q4 apvo Deferred Tax Assets Liability Related To Sale Of Future Royalties
DeferredTaxAssetsLiabilityRelatedToSaleOfFutureRoyalties
5866000
CY2020Q4 apvo Deferred Tax Assets Liability Related To Sale Of Future Royalties
DeferredTaxAssetsLiabilityRelatedToSaleOfFutureRoyalties
473000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
50578000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
44923000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
50245000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
44291000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
333000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
632000
CY2021Q4 apvo Deferred Tax Liability Right Of Use Assets
DeferredTaxLiabilityRightOfUseAssets
333000
CY2020Q4 apvo Deferred Tax Liability Right Of Use Assets
DeferredTaxLiabilityRightOfUseAssets
632000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
333000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
632000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
6000000.0
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
121600000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.010
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.019
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.209
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.241
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.032
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.035
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.011
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.013
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.010
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.012
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000

Files In Submission

Name View Source Status
0001564590-22-011575-index-headers.html Edgar Link pending
0001564590-22-011575-index.html Edgar Link pending
0001564590-22-011575.txt Edgar Link pending
0001564590-22-011575-xbrl.zip Edgar Link pending
apvo-10k_20211231.htm Edgar Link pending
apvo-10k_20211231_htm.xml Edgar Link completed
apvo-20211231.xsd Edgar Link pending
apvo-20211231_cal.xml Edgar Link unprocessable
apvo-20211231_def.xml Edgar Link unprocessable
apvo-20211231_lab.xml Edgar Link unprocessable
apvo-20211231_pre.xml Edgar Link unprocessable
apvo-ex106_519.htm Edgar Link pending
apvo-ex211_9.htm Edgar Link pending
apvo-ex231_12.htm Edgar Link pending
apvo-ex311_11.htm Edgar Link pending
apvo-ex312_13.htm Edgar Link pending
apvo-ex321_10.htm Edgar Link pending
apvo-ex322_6.htm Edgar Link pending
apvo-ex47_128.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g5potoq1tzbl000001.jpg Edgar Link pending
g5potoq1tzbl000002.jpg Edgar Link pending
g5potoq1tzbl000003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending